(384) CNTX-4975 (Trans-Capsaicin) Injection Provides Clinically Meaningful Pain Reduction in Subjects with Painful Intermetatarsal Neuroma (Morton’s Neuroma): A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study

R. Stevens; J. Campbell; I. Gottlieb; K. Guedes; R. Burges; M. Kelly; P. Hanson

doi:10.1016/j.jpain.2017.02.358

(384) CNTX-4975 (Trans-Capsaicin) Injection Provides Clinically Meaningful Pain Reduction in Subjects with Painful Intermetatarsal Neuroma (Morton’s Neuroma): A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study

Journal of Pain ◽

10.1016/j.jpain.2017.02.358 ◽

2017 ◽

Vol 18 (4) ◽

pp. S70

Author(s):

R. Stevens ◽

J. Campbell ◽

I. Gottlieb ◽

K. Guedes ◽

R. Burges ◽

...

Keyword(s):

Pain Reduction ◽

Morton’S Neuroma ◽

Double Blind ◽

Double Blind Placebo ◽

Morton's Neuroma ◽

Dose Ranging

Download Full-text

Faculty Opinions recommendation of A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717967956.793467610 ◽

2012 ◽

Author(s):

Robin Steinhorn

Keyword(s):

Pulmonary Arterial Hypertension ◽

Arterial Hypertension ◽

Sildenafil Citrate ◽

Double Blind ◽

Double Blind Placebo ◽

Treatment Naïve ◽

Dose Ranging ◽

Pulmonary Arterial

Download Full-text

A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study to evaluate the efficacy and safety of VT‐1161 oral tablets in the treatment of patients with distal and lateral subungual onychomycosis of the toenail

British Journal of Dermatology ◽

10.1111/bjd.19224 ◽

2020 ◽

Cited By ~ 1

Author(s):

B. Elewski ◽

S. Brand ◽

T. Degenhardt ◽

S. Curelop ◽

R. Pollak ◽

...

Keyword(s):

Phase Ii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Dose Ranging

Download Full-text

Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study

The Lancet Neurology ◽

10.1016/s1474-4422(08)70173-x ◽

2008 ◽

Vol 7 (9) ◽

pp. 796-804 ◽

Cited By ~ 326

Author(s):

Benjamin M Segal ◽

Cris S Constantinescu ◽

Aparna Raychaudhuri ◽

Lilianne Kim ◽

Rosanne Fidelus-Gort ◽

...

Keyword(s):

Multiple Sclerosis ◽

Phase Ii ◽

Double Blind ◽

Subcutaneous Injections ◽

Double Blind Placebo ◽

Relapsing Remitting ◽

Dose Ranging ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial

The Lancet ◽

10.1016/s0140-6736(16)30307-5 ◽

2016 ◽

Vol 388 (10039) ◽

pp. 31-44 ◽

Cited By ~ 446

Author(s):

Sally Wenzel ◽

Mario Castro ◽

Jonathan Corren ◽

Jorge Maspero ◽

Lin Wang ◽

...

Keyword(s):

Inhaled Corticosteroids ◽

Persistent Asthma ◽

High Dose ◽

Efficacy And Safety ◽

Pivotal Phase ◽

Double Blind ◽

Double Blind Placebo ◽

Dose Ranging ◽

Long Acting ◽

Β2 Agonist

Download Full-text

A randomized, double-blind, placebo-controlled, dose-ranging study of lisdexamfetamine dimesylate augmentation for major depressive disorder in adults with inadequate response to antidepressant therapy

Journal of Psychopharmacology ◽

10.1177/0269881117722998 ◽

2017 ◽

Vol 31 (9) ◽

pp. 1190-1203 ◽

Cited By ~ 5

Author(s):

Cynthia Richards ◽

Dan V Iosifescu ◽

Rajnish Mago ◽

Elias Sarkis ◽

James Reynolds ◽

...

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Antidepressant Therapy ◽

Inadequate Response ◽

Major Depressive ◽

Lisdexamfetamine Dimesylate ◽

Double Blind ◽

Double Blind Placebo ◽

Dose Ranging

Download Full-text

The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial

The Lancet ◽

10.1016/s0140-6736(11)61126-4 ◽

2011 ◽

Vol 378 (9792) ◽

pp. 676-683 ◽

Cited By ~ 216

Author(s):

John GF Cleland ◽

John R Teerlink ◽

Roxy Senior ◽

Evgeny M Nifontov ◽

John JV Mc Murray ◽

...

Keyword(s):

Heart Failure ◽

Cardiac Function ◽

Systolic Heart Failure ◽

Phase 2 ◽

Cardiac Myosin ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Trial ◽

Omecamtiv Mecarbil ◽

Dose Ranging

Download Full-text

Antiviral activity of low-dose alovudine in antiretroviral-experienced patients: results from a 4-week randomized, double-blind, placebo-controlled dose-ranging trial

HIV Medicine ◽

10.1111/j.1468-1293.2007.00444.x ◽

2007 ◽

Vol 8 (3) ◽

pp. 142-147 ◽

Cited By ~ 10

Author(s):

J Ghosn ◽

A-M Quinson ◽

ND Sabo ◽

L Cotte ◽

C Piketty ◽

...

Keyword(s):

Antiviral Activity ◽

Low Dose ◽

Double Blind ◽

Double Blind Placebo ◽

Dose Ranging

Download Full-text

Plecanatide, a Novel Uroguanylin Analog: A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate Efficacy and Safety in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

The American Journal of Gastroenterology ◽

10.14309/00000434-201410002-01831 ◽

2014 ◽

Vol 109 ◽

pp. S541 ◽

Cited By ~ 16

Author(s):

Philip Miner ◽

Robert DeLuca ◽

Marianela La Portilla ◽

Eveline Padila ◽

William Koltun ◽

...

Keyword(s):

Irritable Bowel Syndrome ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Dose Ranging ◽

Irritable Bowel

Download Full-text

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Compare the Efficacy and Safety of Three Doses of Botulinum Toxin Type A (Dysport) With Placebo in Upper Limb Spasticity After Stroke

Stroke ◽

10.1161/01.str.31.10.2402 ◽

2000 ◽

Vol 31 (10) ◽

pp. 2402-2406 ◽

Cited By ~ 190

Author(s):

A. M. O. Bakheit ◽

A. F. Thilmann ◽

A. B. Ward ◽

W. Poewe ◽

J. Wissel ◽

...

Keyword(s):

Botulinum Toxin ◽

Upper Limb ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Limb Spasticity ◽

Dose Ranging

Download Full-text

A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis

American Journal of Obstetrics and Gynecology ◽

10.1016/j.ajog.2018.03.001 ◽

2018 ◽

Vol 218 (6) ◽

pp. 624.e1-624.e9 ◽

Cited By ~ 17

Author(s):

Stephen R. Brand ◽

Thorsten P. Degenhardt ◽

Karen Person ◽

Jack D. Sobel ◽

Paul Nyirjesy ◽

...

Keyword(s):

Vulvovaginal Candidiasis ◽

Phase 2 ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Recurrent Vulvovaginal Candidiasis ◽

Dose Ranging

Download Full-text